Dr. Elena Itskovich hosts Dr. Marco Quarta and Dr. Simone Fentaccini to discuss thedevelopment of Senolytic therapeutics, collaboration between academia, pharma and biotech industry and more. They discuss how these collaborations can bring the field forward and bring therapeutics to market.
Join us in this thought-provoking episode as we learn more about the goals and objectives of the Senolytics Summit by the Phaedon Institute, a highly curated and professional forum that brings together stakeholders from academia, biotechnology, pharmaceuticals, investors, and regulatory bodies to promote advances in the field, support collaboration and coordination, and accelerate research for the benefit of the aging population affected by chronic degenerative diseases.
Find more information https://phaedon.institute
Dr. Marco Quarta - CEO of Rubedo Life Sciences, Co-founder and Director of the Board of Turn Biotechnologies and the founder of the Phaedon Institute and chair of it’s scientific committee.
Dr. Simone Fantaccini - MD, MBA. Co-Founder, SynapseDAO & Pharma Executive, Entrepreneur, Scholar in Emerging Financing Technologies and Open Innovation in Life Sciences
Simone Fantaccini, MD, MBA, is a multi-faceted leader in life sciences, blending expertise in medicine, business, and research. As a Medical Doctor and Executive MBA holder, Simone has significantly impacted clinical medicine, research, and healthcare innovation. His research spans topics of financing strategies in life sciences, as well as their effect on innovation and performance.
Simone is the current Head of Medical Affairs & Chief Scientific Officer at Novartis, where he leads efforts in a range of therapeutic areas and champions cross-functional collaboration to advocate healthcare innovation. Concurrently, he is a Co-Founder at SynapseDAO, a groundbreaking enterprise that focuses on accelerating innovation in neuroscience and immune-mediated disorders through decentralized venture building.
In the entrepreneurial sphere, Simone is also a member of the Board of Advisors at Native Digital DNA, steering the company's innovation in life sciences, particularly in patient safety and product traceability. His previous roles include leadership positions at Biogen and Novartis, where he led high-performing teams and drove operational efficiencies across multiple therapeutic areas.
Renowned for his visionary approach to healthcare, Simone translates scientific research into actionable healthcare solutions. His commitment to performance, strategic partnerships, and innovation has made him a highly sought-after panelist and speaker in the global scientific community.
Dr. Elena Itskovich, an advisor to the Phaedon institue, Co-founder and President of Nest Catalyst , and the host of the mAcademia podcast.
The Phaedon Institute is a nonprofit, charitable organization that operates with the mission of supporting and enabling an effective and sustainable growth of the field of aging and longevity sciences and therapeutics.
The Phaedon Podcast is one of the ways in which we form connections between the different stakeholders in aging research and therapeutics as well as keep an open route of information sharing between aging and longevity experts and the public.
"Guts and Bourbon" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 4.0 License
http://creativecommons.org/licenses/by/4.0/
